Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia

Rev Esp Cardiol (Engl Ed). 2020 Nov;73(11):964-966. doi: 10.1016/j.rec.2020.07.001. Epub 2020 Jul 9.

[Article in English, Spanish]

Authors

Giuseppe Di Tano¹, Renata De Maria², Marco Loffi¹, Luigi Moschini¹, Gianluca Galeazzi¹, Gian Battista Danzi¹

Affiliations

¹ Cardiology Department, ASST Cremona Hospital, Cremona, Italy.
² National Research Council, Institute of Clinical Physiology, ASST Great Metropolitan Hospital Niguarda, Milan, Italy. Electronic address: renata_de_maria@hotmail.com.

No abstract available

Publication types

Case Reports
Comment

MeSH terms

COVID-19 Drug Treatment*
Humans
Hydroxychloroquine* / therapeutic use
Renin-Angiotensin System
SARS-CoV-2

Substances

Hydroxychloroquine